Vigora: UK Status, Risks & the Licensed Equivalent

Vigora is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine. The product is associated with sildenafil, but its regulatory status, contents and quality may not be independently verified. Adults considering treatment for erectile difficulties should discuss suitable, authorised options with a doctor or pharmacist, particularly where other medicines or medical conditions are present.

The product label does not list a manufacturer-claimed tablet strength or dosing schedule. Claimed strengths are manufacturer claims, but no strength is stated for Vigora.

This information must not be interpreted as a dosing instruction. A doctor or pharmacist can advise on an authorised sildenafil medicine if treatment is appropriate.

Vigora is marketed for erectile difficulties in adults. This is a product claim rather than an established medical indication for this product in the United Kingdom. Erectile difficulties can have physical, psychological or medicine-related causes, so assessment by a doctor may identify an underlying condition and more suitable treatment.

A pharmacist can discuss whether a licensed sildenafil medicine or another option is appropriate. The product should not be treated as proof of a diagnosis, and advertised effects may vary because the product is not a licensed United Kingdom medicine.

Sildenafil belongs to a group of medicines that inhibit an enzyme called phosphodiesterase type five. This can help preserve chemical signals involved in relaxation of blood vessels in the penis when sexual stimulation is present, increasing blood flow and supporting an erection. It does not normally create sexual desire and does not produce an erection without sexual stimulation.

The mechanism describes sildenafil as an active ingredient class, not proof that an unlicensed product contains the stated ingredient, strength or quality. A doctor or pharmacist can explain whether this type of treatment is suitable.

Sildenafil-type treatment is not generally intended for use during pregnancy. The marketing material for Vigora does not specify pregnancy or lactation data.

Anyone who is pregnant, planning pregnancy or breastfeeding should discuss the product with a doctor or pharmacist before use. This is particularly relevant because the product is not a licensed medicine in the United Kingdom and its contents cannot be independently verified.

Sildenafil-type treatment is generally used around sexual activity rather than as a routine daily medicine, so a missed-dose approach depends on the prescribed product and schedule. The label does not provide a dosing schedule for Vigora.

Do not take extra product to compensate for a missed dose. A doctor or pharmacist can give advice based on any authorised treatment and the person’s other medicines.

No storage conditions are listed for Vigora. Keep the product in its original packaging, protected from excess heat, moisture and direct light, and out of the reach of children. Follow any storage instructions on the packaging to maintain quality, and do not use a product if its packaging is damaged or its appearance has changed.